BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:11 PM
 | 
Apr 06, 2009
 |  BC Extra  |  Clinical News

Nuvigil meets jet lag disorder endpoints

Cephalon Inc. (NASDAQ:CEPH) said Nuvigil armodafinil met the co-primary endpoints of a significant improvement over placebo as measured by Multiple Sleep Latency Test...

Read the full 103 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >